|
US20160279239A1
(en)
|
2011-05-02 |
2016-09-29 |
Immunomedics, Inc. |
Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
|
|
US20160355591A1
(en)
|
2011-05-02 |
2016-12-08 |
Immunomedics, Inc. |
Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
|
|
TW200838559A
(en)
*
|
2006-11-29 |
2008-10-01 |
Imclone Systems Inc |
Insulin-like growth factor-1 receptor antagonists for modulation of weight and liposity
|
|
PE20090368A1
(es)
|
2007-06-19 |
2009-04-28 |
Boehringer Ingelheim Int |
Anticuerpos anti-igf
|
|
CA2739352C
(en)
|
2008-10-29 |
2021-07-13 |
Wyeth Llc |
Methods for purification of single domain antigen binding molecules
|
|
KR101593285B1
(ko)
*
|
2008-10-29 |
2016-02-11 |
아블린쓰 엔.브이. |
단일 도메인 항원 결합 분자의 제형
|
|
JP5933975B2
(ja)
*
|
2008-11-12 |
2016-06-15 |
メディミューン，エルエルシー |
抗体製剤
|
|
EP2196476A1
(en)
*
|
2008-12-10 |
2010-06-16 |
Novartis Ag |
Antibody formulation
|
|
EP2376116B1
(en)
|
2008-12-12 |
2015-12-09 |
Boehringer Ingelheim International GmbH |
Anti-igf antibodies
|
|
AR080428A1
(es)
|
2010-01-20 |
2012-04-11 |
Chugai Pharmaceutical Co Ltd |
Formulaciones liquidas estabilizadas contentivas de anticuerpos
|
|
WO2012028683A1
(en)
|
2010-09-02 |
2012-03-08 |
Novartis Ag |
Antibody gel system for sustained drug delivery
|
|
EA032336B1
(ru)
*
|
2010-09-17 |
2019-05-31 |
Баксалта Инкорпорейтид |
Стабильная водная иммуноглобулиновая композиция и способ стабилизации иммуноглобулиновой композиции
|
|
TWI616204B
(zh)
|
2010-11-05 |
2018-03-01 |
諾華公司 |
Ｉｌ-１７抗體用於製備治療牛皮癬性關節炎之藥物之用途
|
|
AU2012250924B2
(en)
|
2011-05-02 |
2017-05-25 |
Immunomedics, Inc. |
Ultrafiltration concentration of allotype selected antibodies for small-volume administration
|
|
WO2013063298A1
(en)
*
|
2011-10-26 |
2013-05-02 |
Amgen Inc. |
Methods of reducing or eliminating protein modification and degradation arising from exposure to uv light
|
|
HRP20230065T1
(hr)
|
2011-10-28 |
2023-03-03 |
Prothena Biosciences Limited |
Humanizirana protutijela koja prepoznaju alfa-sinuklein
|
|
SG11201404321YA
(en)
|
2012-01-27 |
2014-08-28 |
Neotope Biosciences Ltd |
Humanized antibodies that recognize alpha-synuclein
|
|
AR092862A1
(es)
*
|
2012-07-25 |
2015-05-06 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de insulina de accion prolongada y un peptido insulinotropico y metodo de preparacion
|
|
AR091902A1
(es)
*
|
2012-07-25 |
2015-03-11 |
Hanmi Pharm Ind Co Ltd |
Formulacion liquida de un conjugado de insulina de accion prolongada
|
|
AR094821A1
(es)
*
|
2012-07-25 |
2015-09-02 |
Hanmi Pharm Ind Co Ltd |
Formulación líquida de un conjugado de péptido insulinotrópico de acción prolongada
|
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
|
BR112015013223A2
(pt)
|
2012-12-26 |
2017-07-11 |
Wockhardt Ltd |
composição farmacêutica
|
|
US20140255413A1
(en)
|
2013-03-07 |
2014-09-11 |
Boehringer Ingelheim International Gmbh |
Combination therapy for neoplasia treatment
|
|
US9700485B2
(en)
|
2013-04-24 |
2017-07-11 |
Corning Incorporated |
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
|
|
NL1040254C2
(en)
*
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
|
US10513555B2
(en)
*
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
|
US9603927B2
(en)
|
2014-02-28 |
2017-03-28 |
Janssen Biotech, Inc. |
Combination therapies with anti-CD38 antibodies
|
|
US9732154B2
(en)
|
2014-02-28 |
2017-08-15 |
Janssen Biotech, Inc. |
Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
|
|
US10562973B2
(en)
|
2014-04-08 |
2020-02-18 |
Prothena Bioscience Limited |
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
|
|
EA202092609A1
(ru)
|
2014-12-04 |
2021-10-29 |
Янссен Байотек, Инк. |
Антитела к cd38 для лечения острого миелолейкоза
|
|
PT3256154T
(pt)
*
|
2015-02-09 |
2020-01-09 |
Ucb Biopharma Sprl |
Composição farmacêutica compreendendo um anticorpo
|
|
CA2986594C
(en)
|
2015-05-20 |
2025-06-10 |
Tufts Medical Center, Inc. |
Anti-CD38 antibodies for the treatment of light chain amyloidosis and other CD38-positive hematological malignancies
|
|
AR104847A1
(es)
*
|
2015-06-17 |
2017-08-16 |
Lilly Co Eli |
Formulación de anticuerpo anti-cgrp
|
|
US20170044265A1
(en)
|
2015-06-24 |
2017-02-16 |
Janssen Biotech, Inc. |
Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
|
|
HUE053366T2
(hu)
*
|
2015-11-03 |
2021-06-28 |
Janssen Biotech Inc |
Szubkután anti-CD38-ellenanyag-készítmények és alkalmazásuk
|
|
JP6992262B2
(ja)
*
|
2016-03-31 |
2022-02-15 |
東ソー株式会社 |
変性抗体測定試薬の製造方法
|
|
US20190233533A1
(en)
|
2016-06-28 |
2019-08-01 |
Umc Utrecht Holding B.V. |
Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38
|
|
CN110352201A
(zh)
|
2017-04-03 |
2019-10-18 |
免疫医疗公司 |
用于癌症疗法的抗体药物缀合物的皮下施用
|
|
CN111565751A
(zh)
|
2017-10-31 |
2020-08-21 |
詹森生物科技公司 |
治疗高危多发性骨髓瘤的方法
|
|
SG11202108627SA
(en)
|
2019-02-18 |
2021-09-29 |
Lilly Co Eli |
Therapeutic antibody formulation
|
|
CN112206320B
(zh)
*
|
2019-07-12 |
2025-02-25 |
鲁南制药集团股份有限公司 |
一种cd47单克隆抗体冻干粉制剂及其制备工艺
|
|
TWI872251B
(zh)
|
2020-05-29 |
2025-02-11 |
日商中外製藥股份有限公司 |
含有抗體製劑
|
|
CN113967195A
(zh)
*
|
2020-07-22 |
2022-01-25 |
三生国健药业（上海）股份有限公司 |
抗her2/pd1双特异性抗体冻干制剂及其制备方法
|